Phase I trial of CCX 354 in volunteers
Phase of Trial: Phase I
Latest Information Update: 09 Nov 2010
At a glance
- Drugs CCX 354 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors ChemoCentryx
- 09 Nov 2010 Results were reported at the Annual American College of Rheumatology Meeting (ACR), according to a ChemoCentryx media release.
- 17 Jun 2010 Pooled analysis presented at the 11th Annual Congress of the European League Against Rheumatism.
- 17 Jun 2010 Results of this trial have been presented at the 2010 Annual European Congress of Rheumatology (EULAR), according to a ChemoCentryx media release.